Non-Cutaneous Melanoma — Trials

Non-Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

312 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 87
Recruiting: 44
Ph III recruiting: 6
Growth YoY: —
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07614828	Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa	withdrawn	Phase 2	0	Eye & ENT Hospital of Fudan UniversityOTHER	1	Jul 10, 2026	clinicaltrials
NCT05545969	Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma(Neo PeLeMM)	withdrawn	Phase 2	0	Melanoma Institute AustraliaOTHER	1	Jun 26, 2024